Use of peptides derived from the A alpha or B beta chain of human fibrinogen for the treatment of shock

Details for Australian Patent Application No. 2005256121 (hide)

International Classifications

Event Publications

27 April 2006 Application Open to Public Inspection

Published as AU-B-2005256121

27 April 2006 PCT application entered the National Phase

PCT publication WO2006/000007 Priority application(s): WO2006/000007

21 August 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Fibrex Medical Research & Development GesmbH, Application No. 2005256121, under INID(43), correct the date to read 05/01/2006

3 March 2011 Application Accepted

Published as AU-B-2005256121

30 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.